CELL ADHESION MOLECULES AS A MARKER REFLECTING THE REDUCTION OF ENDOTHELIAL ACTIVATION INDUCED BY GLUCOCORTICOIDS
Authors:
- Marc LeoneMLMarc Leone
- Brigitte Boutière-AlbanèseBBBrigitte Boutière-Albanèse
- Sarah ValetteSVSarah Valette
- Laurence Camoin-JauLCLaurence Camoin-Jau
- Karine BarrauKBKarine Barrau
- Jacques AlbanèseJAJacques Albanèse
- Claude MartinCMClaude Martin
- Françoise Dignat-GeorgeFDFrançoise Dignat-George
- 1 April 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Shock
- Vol. 21 (4) , 311-314
Abstract
In vitro, steroids down-regulate the expression of cell adhesion molecules (CAMs) in endothelial cells stimulated by lipopolysaccharide. Low-dose hydrocortisone is a new treatment of patients with septic shock, a state that is characterized by an endothelial injury. The aim of the present study was to investigate whether the plasma levels of soluble CAMs, reflecting in vivo endothelial activation, could be modulated in patients with septic shock treated by hydrocortisone. This was a prospective and observational study conducted in the intensive care unit at a university hospital. The subjects included 40 patients with septic shock (American College of Chest Physicians Consensus Conference/Society of Critical Care Medicine definition); 45 healthy blood donors served as controls. The patients receiving the standard care ("reference group") during the first 6 months were compared with the patients receiving the hydrocortisone therapy ("hydrocortisone group") for the next 6 months. Measurements of sCAMs were performed on days 1 and 3 of the disease. On day 1, sE-selectin, sP-selectin, sVCAM-1, and sICAM-1 were significantly elevated in patients with septic shock compared with healthy donors. sE-selectin levels significantly decreased between days 1 and 3 in the "hydrocortisone group," whereas there was no significant change in the "reference group". Surprisingly, sICAM-1 levels significantly increased between days 1 and 3 only in patients treated by hydrocortisone. No significant changes were observed for sP-selectin and sVCAM-1 levels in the two groups. In patients with septic shock, glucocorticoids differently affected the pattern of evolution of sCAMs, with sE-selectin being decreased and sICAM-1 being increased. Expression of sP-selectin and sVCAM-1 was not affected.Keywords
This publication has 24 references indexed in Scilit:
- Corticosteroids in Sepsis: From Bench to Bedside?Shock, 2003
- Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock: A Double-Blind, Randomized, Placebo-controlled, Crossover StudyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Hemodynamic Effects of Early Versus Late Glucocorticosteroid Administration in Experimental Septic ShockShock, 2003
- Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic ShockJAMA, 2002
- Glucocorticoid Receptor Regulates Expression of L-Selectin and CD11/CD18 on Human NeutrophilsCirculation, 1997
- Shedding of L-Selectin as a Mechanism for Reduced Polymorphonuclear Neutrophil Exudation in Patients With the Systemic Inflammatory Response SyndromeArchives of Surgery, 1996
- SYSTEMIC INFLAMMATORY RESPONSE SYNDROMEShock, 1996
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.Proceedings of the National Academy of Sciences, 1990